Na,K-ATPase Acts as a Beta-Amyloid Receptor Triggering Src Kinase Activation

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Beta-amyloid (Aβ) plays a dual role in the brain, implicated in Alzheimer's disease pathology and normal physiological regulation.
• Oligomeric Aβ42 inhibits Na,K-ATPase, contributing to neuronal dysfunction in Alzheimer's disease.
• The physiological function of monomeric Aβ42 interacting with Na,K-ATPase is not well understood.

Purpose of the Study:

• To investigate the physiological role of monomeric Aβ42 interaction with Na,K-ATPase.
• To identify Na,K-ATPase as a potential receptor for Aβ42 monomer.
• To explore the downstream signaling pathways activated by this interaction.

Main Methods:

• Co-localization studies of Aβ42, Na,K-ATPase subunits (α1, β1), and Src kinase in SH-SY5Y neuroblastoma cells.
• Assessment of Src kinase activity following Aβ42 treatment.
• Inhibition studies using pNaKtide to block Na,K-ATPase:Src kinase interaction.
• Evaluation of Aβ42 effects under hypoxic conditions.

Main Results:

• Na,K-ATPase serves as a receptor for monomeric Aβ42.
• Aβ42 monomer triggers Src kinase activation without affecting Na,K-ATPase transport activity.
• Aβ42 co-localizes with Na,K-ATPase α1β1 isozyme and associated Src kinase.
• Inhibition of the Na,K-ATPase:Src kinase complex prevents Aβ-induced Src activation.
• Aβ42's stimulatory effect on Src kinase is abolished under hypoxia.

Conclusions:

• Na,K-ATPase is identified as a receptor for Aβ42 monomer.
• The Aβ42-Na,K-ATPase interaction leads to Src kinase activation, impacting nervous system physiology and pathology.
• This finding opens new avenues for understanding Aβ42 signaling in the brain.